126 related articles for article (PubMed ID: 38643934)
1. AICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure in rats.
Choksey A; Carter RD; Thackray BD; Ball V; Kennedy BWC; Ha LHT; Sharma E; Broxholme J; Castro-Guarda M; Murphy MP; Heather LC; Tyler DJ; Timm KN
J Mol Cell Cardiol; 2024 Jun; 191():12-22. PubMed ID: 38643934
[TBL] [Abstract][Full Text] [Related]
2. AICAR inhibits the Na+/H+ exchanger in rat hearts--possible contribution to cardioprotection.
Moopanar TR; Xiao XH; Jiang L; Chen ZP; Kemp BE; Allen DG
Pflugers Arch; 2006 Nov; 453(2):147-56. PubMed ID: 16983558
[TBL] [Abstract][Full Text] [Related]
3. The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.
Timm KN; Tyler DJ
Cardiovasc Drugs Ther; 2020 Apr; 34(2):255-269. PubMed ID: 32034646
[TBL] [Abstract][Full Text] [Related]
4. Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts.
Chabowski A; Momken I; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
Mol Cell Biochem; 2006 Aug; 288(1-2):201-12. PubMed ID: 16710744
[TBL] [Abstract][Full Text] [Related]
5. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.
Hasenour CM; Ridley DE; Hughey CC; James FD; Donahue EP; Shearer J; Viollet B; Foretz M; Wasserman DH
J Biol Chem; 2014 Feb; 289(9):5950-9. PubMed ID: 24403081
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: potential role of AMP-activated protein kinase.
Kristiansen SB; Solskov L; Jessen N; Løfgren B; Schmitz O; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Lund S
Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):10-6. PubMed ID: 19486332
[TBL] [Abstract][Full Text] [Related]
7. Activation of AMPK alleviates cardiopulmonary bypass-induced cardiac injury via ameliorating acute cardiac glucose metabolic disorder.
Wang Z; Cao Y; Yin Q; Han Y; Wang Y; Sun G; Zhu H; Xu M; Gu C
Cardiovasc Ther; 2018 Dec; 36(6):e12482. PubMed ID: 30632675
[TBL] [Abstract][Full Text] [Related]
8. Metformin improves cardiac function in rats via activation of AMP-activated protein kinase.
Wang XF; Zhang JY; Li L; Zhao XY; Tao HL; Zhang L
Clin Exp Pharmacol Physiol; 2011 Feb; 38(2):94-101. PubMed ID: 21143620
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes.
Gaidhu MP; Fediuc S; Ceddia RB
J Biol Chem; 2006 Sep; 281(36):25956-64. PubMed ID: 16816404
[TBL] [Abstract][Full Text] [Related]
10. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
[TBL] [Abstract][Full Text] [Related]
11. AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo.
Shearer J; Fueger PT; Rottman JN; Bracy DP; Martin PH; Wasserman DH
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E871-7. PubMed ID: 15265760
[TBL] [Abstract][Full Text] [Related]
12. Chronic AMP-activated protein kinase activation and a high-fat diet have an additive effect on mitochondria in rat skeletal muscle.
Fillmore N; Jacobs DL; Mills DB; Winder WW; Hancock CR
J Appl Physiol (1985); 2010 Aug; 109(2):511-20. PubMed ID: 20522731
[TBL] [Abstract][Full Text] [Related]
13. Short-term AMP-regulated protein kinase activation enhances insulin-sensitive fatty acid uptake and increases the effects of insulin on fatty acid oxidation in L6 muscle cells.
Kelly KR; Abbott MJ; Turcotte LP
Exp Biol Med (Maywood); 2010 Apr; 235(4):514-21. PubMed ID: 20407084
[TBL] [Abstract][Full Text] [Related]
14. AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo.
Iglesias MA; Furler SM; Cooney GJ; Kraegen EW; Ye JM
Diabetes; 2004 Jul; 53(7):1649-54. PubMed ID: 15220186
[TBL] [Abstract][Full Text] [Related]
15. Microarray expression analysis in delayed cardioprotection: the effect of exercise, AICAR, or metformin and the possible role of AMP-activated protein kinase (AMPK).
Solskov L; Magnusson NE; Kristiansen SB; Jessen N; Nielsen TT; Schmitz O; Bøtker HE; Lund S
Mol Cell Biochem; 2012 Jan; 360(1-2):353-62. PubMed ID: 21964537
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent cardiac function during experimental sepsis: effect of pharmacological activation of AMP-activated protein kinase by AICAR.
Inata Y; Piraino G; Hake PW; O'Connor M; Lahni P; Wolfe V; Schulte C; Moore V; James JM; Zingarelli B
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H826-H837. PubMed ID: 29979626
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
Zhuge J
Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
[TBL] [Abstract][Full Text] [Related]
18. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR.
Russell RR; Bergeron R; Shulman GI; Young LH
Am J Physiol; 1999 Aug; 277(2):H643-9. PubMed ID: 10444490
[TBL] [Abstract][Full Text] [Related]
19. Regulation of visceral and subcutaneous adipocyte lipolysis by acute AICAR-induced AMPK activation.
Anthony NM; Gaidhu MP; Ceddia RB
Obesity (Silver Spring); 2009 Jul; 17(7):1312-7. PubMed ID: 19214174
[TBL] [Abstract][Full Text] [Related]
20. Chronic AICAR treatment prevents metabolic changes in cardiomyocytes exposed to free fatty acids.
Viglino C; Foglia B; Montessuit C
Pflugers Arch; 2019 Sep; 471(9):1219-1234. PubMed ID: 31152240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
